Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BioStem Technologies Expands Product Access in Medicaid
-
BioStem Technologies Reports Third Quarter 2025 Financial Results
-
BioStem Technologies Announces Filing of Restated Financial Statements
-
BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes
-
BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters
-
BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers
-
BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025
-
BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant
-
BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program
-
BioStem Showcasing its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting